Holen Sie sich die Stockscreener-App
64.41
0.48%
0.3078
Handel nachbörslich:
64.43
0.0185
+0.03%
Schlusskurs vom Vortag:
$64.10
Offen:
$65
24-Stunden-Volumen:
4,575
Relative Volume:
0.57
Marktkapitalisierung:
$281.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.86%
1M Leistung:
+2.84%
6M Leistung:
-8.78%
1J Leistung:
+1.23%
1-Tages-Spanne:
$64.41
$65.00
1-Wochen-Bereich:
$62.25
$65.00
52-Wochen-Spanne:
$54.52
$72.84
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Firmenname
Invesco Biotechnology Genome Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PBE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
64.41 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
293.34 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
595.93 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
598.77 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
230.77 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
528.77 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Aktie (PBE) Neueste Nachrichten
Citadel Advisors LLC Grows Stake in Innovator U.S. Equity Ultra Buffer ETF – January (BATS:UJAN) - Defense World
8,551 Shares in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Acquired by Citadel Advisors LLC - Defense World
Bank of America Corp DE Has $4.59 Million Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - sharewise
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Stake Lessened by Cetera Investment Advisers - Defense World
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Stifel Financial Corp Acquires 16,892 Shares of RiverNorth Managed Duration Municipal Income Fund II, Inc. (NYSEARCA:RMMZ) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Tower Research Capital LLC TRC - Defense World
Stifel Financial Corp Sells 600 Shares of SRH Total Return Fund, Inc. (NYSE:STEW) - Defense World
Stifel Financial Corp Sells 1,457 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Stifel Financial Corp Grows Stock Holdings in Schwab U.S. REIT ETF (NYSEARCA:SCHH) - Defense World
Susquehanna International Group LLP Makes New Investment in VictoryShares Core Intermediate Bond ETF (NASDAQ:UITB) - Defense World
Stifel Financial Corp Acquires 5,291 Shares of T. Rowe Price Dividend Growth ETF (NYSEARCA:TDVG) - Defense World
Hsbc Holdings PLC Grows Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Hsbc Holdings PLC Purchases 16,554 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Barclays PLC Buys 10,174 Shares of FT Vest U.S. Equity Enhance & Moderate Buffer ETF – January (NYSEARCA:XJAN) - Defense World
16,974 Shares in VNET Group, Inc. (NASDAQ:VNET) Bought by Tower Research Capital LLC TRC - Defense World
Tower Research Capital LLC TRC Lowers Position in The Marcus Co. (NYSE:MCS) - Defense World
Hsbc Holdings PLC Has $232,000 Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Hsbc Holdings PLC Takes Position in Vir Biotechnology, Inc. (NASDAQ:VIR) - Defense World
Tower Research Capital LLC TRC Has $71,000 Holdings in CTO Realty Growth, Inc. (NYSE:CTO) - Defense World
Dimensional Fund Advisors LP Raises Stake in REGENXBIO Inc. (NASDAQ:RGNX) - Defense World
Dimensional Fund Advisors LP Raises Holdings in Blue Foundry Bancorp (NASDAQ:BLFY) - Defense World
Klaviyo, Inc. (NYSE:KVYO) Shares Bought by Tower Research Capital LLC TRC - Defense World
LENZ Therapeutics’ (LENZ) “Buy” Rating Reiterated at HC Wainwright - Defense World
Gladstone Commercial Co. (NASDAQ:GOOD) Stake Raised by Dimensional Fund Advisors LP - Defense World
Hsbc Holdings PLC Makes New Investment in Customers Bancorp, Inc. (NYSE:CUBI) - Defense World
Stifel Nicolaus Issues Pessimistic Forecast for Russel Metals (TSE:RUS) Stock Price - Defense World
(PBE) Investment Analysis - news.stocktradersdaily.com
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
Diamond Hill Investment Group, Inc. (NASDAQ:DHIL) Shares Sold by First Trust Advisors LP - Defense World
Marshall Wace LLP Purchases Shares of 38,500 908 Devices Inc. (NASDAQ:MASS) - Defense World
Raymond James Financial Inc. Purchases New Shares in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Stock Holdings Lowered by LPL Financial LLC - Defense World
Envestnet Asset Management Inc. Raises Stake in Invesco S&P 500 Equal Weight Materials ETF (NYSEARCA:RSPM) - Defense World
Envestnet Asset Management Inc. Invests $1.41 Million in Atour Lifestyle Holdings Limited (NASDAQ:ATAT) - Defense World
T. Rowe Price Ultra Short-Term Bond ETF (NYSEARCA:TBUX) Shares Sold by Envestnet Asset Management Inc. - Defense World
BlackRock Municipal Income Trust II (NYSE:BLE) Shares Acquired by Invesco Ltd. - Defense World
Wells Fargo & Company MN Acquires 4,396 Shares of Peoples Bancorp Inc. (NASDAQ:PEBO) - Defense World
Russell Investments Group Ltd. Grows Holdings in Capricor Therapeutics Inc (NASDAQ:CAPR) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Russell Investments Group Ltd. - Defense World
Bank of Montreal Can Cuts Stock Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco S&P SmallCap Information Technology ETF (NASDAQ:PSCT) Shares Sold by Wells Fargo & Company MN - Defense World
Wells Fargo & Company MN Decreases Stake in Invesco Trust for Investment Grade Municipals (NYSE:VGM) - Defense World
Wells Fargo & Company MN Decreases Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Eli Lilly and Co (NYSE:LLY): Promising Breakthrough in Weight-Loss Treatments - Value The Markets
When (PBE) Moves Investors should Listen - news.stocktradersdaily.com
LPL Financial LLC Increases Position in ProShares Nasdaq-100 High Income ETF (NASDAQ:IQQQ) - Defense World
LPL Financial LLC Boosts Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Raymond James Financial Inc. Purchases Shares of 18,878 Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Raymond James Financial Inc. Takes Position in PIMCO Municipal Income Fund III (NYSE:PMX) - Defense World
Finanzdaten der Invesco Biotechnology Genome Etf-Aktie (PBE)
Es liegen keine Finanzdaten für Invesco Biotechnology Genome Etf (PBE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):